W

WSI Co Ltd
KOSDAQ:299170

Watchlist Manager
WSI Co Ltd
KOSDAQ:299170
Watchlist
Price: 3 210 KRW Market Closed
Market Cap: ₩133.2B

WSI Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

WSI Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
W
WSI Co Ltd
KOSDAQ:299170
EPS (Diluted)
₩35
CAGR 3-Years
-46%
CAGR 5-Years
28%
CAGR 10-Years
N/A
C
Chorokbaem Healthcare Co Ltd
KRX:118000
EPS (Diluted)
₩61
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Wonik Co Ltd
KOSDAQ:032940
EPS (Diluted)
₩1.6k
CAGR 3-Years
9%
CAGR 5-Years
64%
CAGR 10-Years
N/A
H
HLB Life Science Co Ltd
KOSDAQ:067630
EPS (Diluted)
-₩1.5k
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
-16%
B
BlueMTec Co Ltd
KOSDAQ:439580
EPS (Diluted)
-₩146
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

WSI Co Ltd
Glance View

Market Cap
133.2B KRW
Industry
Health Care

WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.

Intrinsic Value
1 696.71 KRW
Overvaluation 47%
Intrinsic Value
Price
W

See Also

What is WSI Co Ltd's EPS (Diluted)?
EPS (Diluted)
35.6 KRW

Based on the financial report for Dec 31, 2024, WSI Co Ltd's EPS (Diluted) amounts to 35.6 KRW.

What is WSI Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
28%

Over the last year, the EPS (Diluted) growth was -52%. The average annual EPS (Diluted) growth rates for WSI Co Ltd have been -46% over the past three years , 28% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett